sk&f 83959 has been researched along with amphetamine in 1 studies
Studies (sk&f 83959) | Trials (sk&f 83959) | Recent Studies (post-2010) (sk&f 83959) | Studies (amphetamine) | Trials (amphetamine) | Recent Studies (post-2010) (amphetamine) |
---|---|---|---|---|---|
94 | 0 | 46 | 13,071 | 329 | 1,977 |
Protein | Taxonomy | sk&f 83959 (IC50) | amphetamine (IC50) |
---|---|---|---|
Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | 0.96 | |
Cytochrome P450 2A6 | Homo sapiens (human) | 3.5 | |
Cytochrome P450 2A5 | Mus musculus (house mouse) | 2.85 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.96 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.96 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, T; George, SR; Perreault, ML; Shen, MY | 1 |
1 other study(ies) available for sk&f 83959 and amphetamine
Article | Year |
---|---|
The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Motor Activity; Multiprotein Complexes; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward | 2015 |